Trials / Completed
CompletedNCT00434447
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
A Phase IV Study of Zoledronic Acid Therapy in Patients With Bone Metastases From Breast Cancer or Hormone Resistant Prostate Cancer, or Bone Involvement From Multiple Myeloma, Assessing Long-term Efficacy and Safety
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to monitor the safety and efficacy of long-term treatment with zoledronic acid by assessing the incidence of, renal impairment, osteonecrosis of the jaw(ONJ), overall safety and skeletal related events (SREs) beyond 12 months treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2009-09-01
- First posted
- 2007-02-13
- Last updated
- 2017-02-27
Locations
10 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00434447. Inclusion in this directory is not an endorsement.